Deal Structure & Valuation
Reports involving deal structure & valuation
The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
This Report is the pharmaceutical and biotech industry’s standard reference work on royalty rates, published annually by PharmaVentures, the experts in deals and alliances, now online and fully interactive. The 2012 Report presents major new case studies, and provides full, new data and analysis based on data from the premier agreements database, PharmaDeals v4, and other sources. Topics include Royalties and Deal Structures, Sales Milestones, Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication.
Essential Deal Trends: Oncology 2011
Essential Deal Trends publishes a new report based on key therapeutic areas every month, such as Oncology, Diseases of the Cardiovascular System, Vaccines, or Diseases of the Central Nervous System. For those fast-moving areas, such as Oncology, we update the report every 6 months, to ensure you have the latest trends at your instant disposal. Whether you’re interested in Mergers and Acquisitions, Licensing deals, or more exotic deal structures, Essential Deal Trends offers expert analysis from Senior Consultants and Advisors at PharmaVentures.
The Royalty Rate Report 2011: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
This Report is the pharmaceutical and biotech industry’s standard reference work on royalty rates, published annually by PharmaVentures, the experts in deals and alliances, now online and fully interactive. The 2011 Report presents major new case studies, and provides full, new data and analysis based on data from the premier agreements database, PharmaDeals v4, and other sources. Topics include Royalties and Deal Structures, Sales Milestones, Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication.
Analysis of Deal Making in Vaccines
This essential new PharmaDeals® report will help you to identify market size and trends and who your prospective partners are within the area of vaccines deal making.
